Genomic alterations in paired pretreatment (pre) and progression (prog) tumor samples from ovarian cancer patients (pts) treated with pazopanib (pazo) or placebo (plb)

Autor:	Sandrina Lambrechts, Anthony D'Amelio, Jae Weon Kim, Philipp Harter, Andres Poveda, Yuan Liu, Ulrich Canzler, Tjoung-Won Park-Simon, Gabriele Feisel, Nuria Lainez, Robert C. Gagnon, Alexander Burges, Annette Jahn, Ionel Mitrica, Rafael ÃÂlvarez Gallego, Sang Yoon Park, Kosei Hasegawa, Catherine Barrett, Florian Heitz, Mansoor Raza Mirza
Rok vydání:	2014
Předmět:	Oncology Cancer Research medicine.medical_specialty Chemotherapy endocrine system diseases Somatic cell business.industry medicine.medical_treatment medicine.disease Bioinformatics Placebo female genital diseases and pregnancy complications Pazopanib Internal medicine medicine Mutational status Ovarian cancer business medicine.drug
Zdroj:	Journal of Clinical Oncology. 32:5501-5501
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2014.32.15_suppl.5501
Popis:	5501 Background: BRCA mutational status, in combination with the accumulation of somatic mutations, has been associated with ovarian cancer prog and response to chemotherapy. AGO-OVAR16/VEG110655 i...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::30d350901e8105d912dbc757f27e0ce0 https://doi.org/10.1200/jco.2014.32.15_suppl.5501 Zobrazit plný text záznamu